Works by Gotoh, Moritaka


Results: 39
    1
    2
    3
    4
    5
    6

    Phase 1 trial of gemtuzumab ozogamicin in combination with enocitabine and daunorubicin for elderly patients with relapsed or refractory acute myeloid leukemia: Japan Adult Leukemia Study Group (JALSG)-GML208 study.

    Published in:
    International Journal of Hematology, 2012, v. 96, n. 4, p. 485, doi. 10.1007/s12185-012-1165-z
    By:
    • Ito, Yoshikazu;
    • Wakita, Atsushi;
    • Takada, Satoru;
    • Mihara, Masahiro;
    • Gotoh, Moritaka;
    • Ohyashiki, Kazuma;
    • Ohtake, Shigeki;
    • Miyawaki, Shuichi;
    • Ohnishi, Kazunori;
    • Naoe, Tomoki
    Publication type:
    Article
    7
    8
    9
    10
    11
    12

    Tyrosine Kinase Inhibitors Do Not Promote a Decrease in SARS-CoV-2 Anti-Spike IgG after BNT162b2 Vaccination in Chronic Myeloid Leukemia: A Prospective Observational Study.

    Published in:
    Vaccines, 2022, v. 10, n. 9, p. 1404, doi. 10.3390/vaccines10091404
    By:
    • Katagiri, Seiichiro;
    • Akahane, Daigo;
    • Otsuki, Shunsuke;
    • Suto, Arisa;
    • Yamada, Akiko;
    • Suguro, Tamiko;
    • Asano, Michiyo;
    • Yoshizawa, Seiichiro;
    • Tanaka, Yuko;
    • Furuya, Nahoko;
    • Fujimoto, Hiroaki;
    • Okabe, Seiichi;
    • Gotoh, Moritaka;
    • Ito, Yoshikazu;
    • Gotoh, Akihiko
    Publication type:
    Article
    13

    BIM deletion polymorphism accounts for lack of favorable outcome in Japanese females with follicular lymphoma.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 5, p. 1283, doi. 10.1080/10428194.2018.1529310
    By:
    • Ito, Yoshikazu;
    • Umezu, Tomohiro;
    • Tadokoro, Kenichi;
    • Saito, Yuu;
    • Katagiri, Seiichiro;
    • Suguro, Tamiko;
    • Asano, Michiyo;
    • Yoshizawa, Seiichiro;
    • Akahane, Daigo;
    • Tanaka, Yuko;
    • Fujimoto, Hiroaki;
    • Okabe, Seiichi;
    • Gotoh, Moritaka;
    • Tauchi, Tetsuzo;
    • Kawana, Chiaki;
    • Ohyashiki, Junko H.;
    • Nakamura, Naoya;
    • Ohyashiki, Kazuma
    Publication type:
    Article
    14

    Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 6, p. 1332, doi. 10.1080/10428194.2017.1387913
    By:
    • Motohashi, Kenji;
    • Fujisawa, Shin;
    • Doki, Noriko;
    • Kobayashi, Takeshi;
    • Mori, Takehiko;
    • Usuki, Kensuke;
    • Tanaka, Masatsugu;
    • Fujiwara, Shinichiro;
    • Kako, Shinichi;
    • Aoyama, Yasuyuki;
    • Onoda, Masahiro;
    • Yano, Shingo;
    • Gotoh, Moritaka;
    • Kanamori, Heiwa;
    • Takahashi, Satoshi;
    • Okamoto, Shinichiro;
    • for the Kanto Study Group for Cell Therapy (KSGCT)
    Publication type:
    Article
    15

    Autologous hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission: outcomes before and after the introduction of arsenic trioxide.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 5, p. 1061, doi. 10.1080/10428194.2016.1231406
    By:
    • Yanada, Masamitsu;
    • Yano, Shingo;
    • Kanamori, Heiwa;
    • Gotoh, Moritaka;
    • Emi, Nobuhiko;
    • Watakabe, Kyoko;
    • Kurokawa, Mineo;
    • Nishikawa, Akinori;
    • Mori, Takehiko;
    • Tomita, Naoto;
    • Murata, Makoto;
    • Hashimoto, Hisako;
    • Henzan, Hideho;
    • Kanda, Yoshinobu;
    • Sawa, Masashi;
    • Kohno, Akio;
    • Atsuta, Yoshiko;
    • Ichinohe, Tatsuo;
    • Takami, Akiyoshi
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 11, p. 2763, doi. 10.1007/s00277-021-04607-8
    By:
    • Tachibana, Takayoshi;
    • Kanda, Junya;
    • Ishizaki, Takuma;
    • Najima, Yuho;
    • Tanaka, Masatsugu;
    • Doki, Noriko;
    • Fujiwara, Shin-ichiro;
    • Kimura, Shun-ichi;
    • Onizuka, Makoto;
    • Takahashi, Satoshi;
    • Saito, Takeshi;
    • Mori, Takehiko;
    • Fujisawa, Shin;
    • Sakaida, Emiko;
    • Miyazaki, Takuya;
    • Aotsuka, Nobuyuki;
    • Gotoh, Moritaka;
    • Watanabe, Reiko;
    • Shono, Katsuhiro;
    • Kanamori, Heiwa
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study.

    Published in:
    PLoS ONE, 2021, v. 15, n. 7, p. 1, doi. 10.1371/journal.pone.0253025
    By:
    • Yamada, Akiko;
    • Araki, Yoichi;
    • Tanaka, Yuko;
    • Otsuki, Shunsuke;
    • Yamada, Arisa;
    • Moriyama, Mitsuru;
    • Katagiri, Seiichiro;
    • Suguro, Tamiko;
    • Asano, Michiyo;
    • Yoshizawa, Seiichiro;
    • Akahane, Daigo;
    • Furuya, Nahoko;
    • Fujimoto, Hiroaki;
    • Okabe, Seiichi;
    • Gotoh, Moritaka;
    • Suzuki, Kunihito;
    • Saito, Kazuhiro;
    • Gotoh, Akihiko
    Publication type:
    Article
    39